Planta Med 2016; 82(04): 337-343
DOI: 10.1055/s-0035-1558290
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

In Vitro TNF-α Inhibition Elicited by Extracts from Echinodorus grandiflorus Leaves and Correlation with Their Phytochemical Composition

Eliana de Faria Garcia
1   Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
,
Mariana Assíria de Oliveira
1   Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
,
Luana Pereira Antunes Dourado
2   Department of Microbiology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
,
Danielle Glória de Souza
2   Department of Microbiology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
,
Mauro Martins Teixeira
3   Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
,
Fernão Castro Braga
1   Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 09. Januar 2015
revised 06. Oktober 2015

accepted 24. Oktober 2015

Publikationsdatum:
21. Dezember 2015 (online)

Abstract

This study aimed to evaluate the effect of various extracts and fractions obtained from Echinodorus grandiflorus leaves on tumor necrosis factor-α release by lipopolysaccharide-stimulated THP-1 cells, as well as to look at the association between bioactivity and phytochemical composition. To this end, a high-performance liquid chromatography with diode-array detection method was developed and validated, enabling the quantification of seven compounds in E. grandiflorus extracts and fractions. All of these samples showed antitumor necrosis factor-α activity, however, extracts prepared from 50 % EtOH, water and dichloromethane, and a flavonoid-rich fraction elicited the most potent responses. trans-Aconitic acid and isoorientin were the major compounds in some preparations. Polynomial regression analysis showed the association between the contents of swertiajaponin, swertisin, trans-aconitic, and chicoric acids with the antitumor necrosis factor-α activity of the extracts and fractions. None of the compounds tested alone abolished tumor necrosis factor-α release completely, however, some extracts and fractions reached this result, suggesting a synergistic effect between the constituents. Therefore, it is clearly shown that the species E. grandiflorus has significant in vitro antitumor necrosis factor-α activity, a promising characteristic that deserves further investigations in the search for new anti-inflammatory agents from plants.

Supporting Information

 
  • References

  • 1 Lorenzi H, Matos FJA. Plantas Medicinais no Brasil: nativas e exóticas cultivadas. São Paulo: Instituto Plantarum; 2002: 39-40
  • 2 Manns D, Hartmann R. Echinodol: a new cembrene derivative from Echinodorus grandiflorus . Planta Med 1993; 59: 465-466
  • 3 Tanaka CMA, Sarragiotto MH, Schpector JZ, Marsaioli AJ. A cembrane from Echinodorus grandiflorus . Phytochemistry 1997; 44: 1547-1549
  • 4 Costa M, Tanaka CMA, Imamura PM, Marsaioli AJ. Isolation and synthesis of a new clerodane from Echinodorus grandiflorus . Phytochemistry 1999; 50: 117-122
  • 5 Tanaka CMA. Constituintes químicos de cinco espécies de Echinodorus e avaliação do beta-pineno como substrato para obtenção de quirons mais elaborados [PhD thesis]. Campinas: Universidade Estadual de Campinas; 2000
  • 6 Schnitzler M, Petereit F, Nahrstedt A. Trans-aconitic acid, glucosylflavones and hydroxycinnamoyltartaric acids from the leaves of Echinodorus grandiflorus ssp. aureus, a Brazilian medicinal plant. Rev Bras Farmacogn 2007; 17: 149-154
  • 7 Garcia EF, Oliveira MA, Godin AM, Ferreira WC, Bastos LFS, Coelho MM, Braga FC. Antiedematogenic activity and phytochemical composition of preparations from Echinodorus grandiflorus leaves. Phytomedicine 2010; 18: 80-86
  • 8 Dutra RC, Tavares CZ, Ferraz SO, Sousa OV, Pimenta DS. Investigação das atividades analgésica e anti-inflamatória do extrato metanólico dos rizomas de Echinodorus grandiflorus . Rev Bras Farmacogn 2006; 16: 469-474
  • 9 Pimenta DS. Ecologia, cultivo e validação do uso de Echinodorus grandiflorus (Cham. & Schltdl.) Micheli (chapeú de couro) [PhD thesis]. Rio de Janeiro: Fundação Oswaldo Cruz; 2002
  • 10 Brugiolo AS, Alves CC, Gouveia AC, Dias AT, Rodrigues MF, Pacífico LG, Aarestrup BJ, Machado MA, Domingues R, Teixeira HC, Gameiro J, Ferreira AP. Effects of aqueous extract of Echinodorus grandiflorus on the immune response in ovalbumin-induced pulmonary allergy. Ann Allergy Asthma Immunol 2011; 106: 481-488
  • 11 FDA – Food and Drug Administration. Guidance for industry: analytical procedures and methods validation. 2000. Available at. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm122858.pdf Accessed October 15, 2010
  • 12 Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol 2008; 46: 409-420
  • 13 Al-Nahain A, Jahan R, Rahmatullah M. Zingiber officinale: a potential plant against rheumatoid arthritis. Arthritis 2014; 2014: 159089
  • 14 Dey D, Chaskar S, Athavale N, Chitre D. Inhibition of LPS-induced TNF-α and NO production in mouse macrophage and inflammatory response in rat animal models by a novel Ayurvedic formulation, BV-9238. Phytother Res 2014; 28: 1479-1485
  • 15 Lee W, Ku SK, Bae JS. Vascular barrier protective effects of orientin and isoorientin in LPS-induced inflammation in vitro and in vivo . Vascul Pharmacol 2014; 62: 3-14
  • 16 Huang ST, Chenn CT, Chieng KT, Huang SH, Chiang BH, Wang LF, Kuo HS, Lin CM. Inhibitory effects of a rice hull constituent on tumor necrosis factor alpha, prostaglandin E2, and cyclooxygenase-2 production in lipopolysaccharide-activated mouse macrophages. Ann N Y Acad Sci 2005; 1042: 387-395
  • 17 Park CM, Jin KS, Lee YW, Song YS. Luteolin and chicoric acid synergistically inhibited inflammatory responses via inactivation of PI3 K-Akt pathway and impairment of NF-κB translocation in LPS stimulated RAW 264.7 cells. Eur J Pharmacol 2011; 660: 454-459
  • 18 Yan SK, Lin ZY, Dai WX, Shi QR, Liu XH, Jin HZ, Zhang WD. Chemometrics-based approach to modeling quantitative composition-activity relationships for Radix Tinosporae. Interdiscip Sci 2010; 3: 221-227
  • 19 Dalby-Brown L, Barsett H, Landbo AK, Meyer AS, Molgaard P. Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteins. J Agric Food Chem 2005; 53: 9413-9423
  • 20 Takuko K, Shinʼichi Y, Isao O, Hirohiko M, Masaki H. Antioxidant ability of chicoric acid and its analogous compounds. Nippon Kagaku Kaishi 1999; 11: 739-750
  • 21 Zheng KY, Zhang ZX, Du CY, Zhang WL, Bi CW, Choi RC, Dong TT, Tsim KW. Ferulic acid enhances the chemical and biological properties of Astragali Radix: a stimulator for danggui buxue tang, an ancient Chinese herbal decoction. Planta Med 2014; 80: 159-164
  • 22 Wölfle U, Haarhaus B, Schempp CM. The photoprotective and antioxidative properties of luteolin are synergistically augmented by tocopherol and ubiquinone. Planta Med 2013; 79: 963-965
  • 23 Kurin E, Atanasov AG, Donath O, Heiss EH, Dirsch VM, Nagy M. Synergy study of the inhibitory potential of red wine polyphenols on vascular smooth muscle cell proliferation. Planta Med 2012; 78: 772-778
  • 24 ICH – International Conference on Harmonization of Technical Requirements for Registration of Pharmaceutical for Human Use. ICH Harmonised Tripartite Guideline. Text on Validation of Analytical Procedures, Q2 A (CPMP/ICH/381/94). London: European Agency for the Evaluation of Medicinal Products; 1994
  • 25 ICH – International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceutical for Human Use. ICH Harmonised Tripartite Guideline. Validation of Analytical Procedures: Methodology, Q2B (CPMP/ICH/281/96). London: European Agency for the Evaluation of Medicinal Products; 1996
  • 26 Ministry of Health, Health Surveillance Agency. Resolution no. 899 from 29 May 2003. Brazil: Diário Oficial da União; 2003
  • 27 Weiss T, Shalit I, Blau H, Werber S, Haplerin D, Levitov A, Fabian I. Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-κB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines. Antimicrob Agents Chemother 2004; 48: 1974-1982